Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual mechanism of type VII collagen transfer by bone marrow mesenchymal stem cell extracellular vesicles to recessive dystrophic epidermolysis bullosa fibroblasts
Jeffrey D. McBride, Luis Rodriguez-Menocal, Ambar Candanedo, et al.
Biochimie (2018) Vol. 155, pp. 50-58
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles
Kyong‐Su Park, Elga Bandeira, Ganesh Vilas Shelke, et al.
Stem Cell Research & Therapy (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 211
Functional proteins of mesenchymal stem cell-derived extracellular vesicles
Guanguan Qiu, Guoping Zheng, Menghua Ge, et al.
Stem Cell Research & Therapy (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 166
Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes
Byung‐Chul Lee, Insung Kang, Kyung–Rok Yu
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 711-711
Open Access | Times Cited: 136
Extracellular vesicles: Emerging frontiers in wound healing
Mangesh Dattu Hade, Caitlin N. Suire, James Mossell, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 6, pp. 2102-2125
Closed Access | Times Cited: 81
An Effective Peptide-Based Platform for Efficient Exosomal Loading and Cellular Delivery of a microRNA
Mangesh Dattu Hade, Caitlin N. Suire, Zucai Suo
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 3, pp. 3851-3866
Closed Access | Times Cited: 39
Innovations in the Treatment of Dystrophic Epidermolysis Bullosa (DEB): Current Landscape and Prospects
Ping‐Chen Hou, Nathalie del Agua, Su M. Lwin, et al.
Therapeutics and Clinical Risk Management (2023) Vol. Volume 19, pp. 455-473
Open Access | Times Cited: 28
Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa
Ellie Rashidghamat, Tendai Kadiyirire, Salma Ayis, et al.
Journal of the American Academy of Dermatology (2019) Vol. 83, Iss. 2, pp. 447-454
Open Access | Times Cited: 65
Investigational Treatments for Epidermolysis Bullosa
Ping‐Chen Hou, Han‐Tang Wang, Stasha Sonia Abhee, et al.
American Journal of Clinical Dermatology (2021) Vol. 22, Iss. 6, pp. 801-817
Closed Access | Times Cited: 44
Intravenous allogeneic umbilical cord blood–derived mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa patients
Sang Eun Lee, Seung‐Ju Lee, Song‐Ee Kim, et al.
JCI Insight (2021) Vol. 6, Iss. 2
Open Access | Times Cited: 39
Extracellular Vesicles as Therapeutic Tools for the Treatment of Chronic Wounds
Eric R. Bray, Alisha Oropallo, Daniel A. Grande, et al.
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1543-1543
Open Access | Times Cited: 38
Characterisation of Matrix-Bound Nanovesicles (MBVs) Isolated from Decellularised Bovine Pericardium: New Frontiers in Regenerative Medicine
Dalila Di Francesco, Carolina Di Varsavia, Simona Casarella, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 740-740
Open Access | Times Cited: 4
IL-1β–Primed Mesenchymal Stromal Cells Improve Epidermal Substitute Engraftment and Wound Healing via Matrix Metalloproteinases and Transforming Growth Factor-β1
Brice Magne, Marianne Dedier, Muriel Nivet, et al.
Journal of Investigative Dermatology (2019) Vol. 140, Iss. 3, pp. 688-698.e21
Open Access | Times Cited: 37
Exosomes: Emerging Diagnostic and Therapeutic Targets in Cutaneous Diseases
Abdul Quaiyoom Khan, Sabah Akhtar, Kirti S. Prabhu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9264-9264
Open Access | Times Cited: 33
ABCB5+ Dermal Mesenchymal Stromal Cells with Favorable Skin Homing and Local Immunomodulation for Recessive Dystrophic Epidermolysis Bullosa Treatment
Julia Riedl, Michael Pickett‐Leonard, Cindy Eide, et al.
Stem Cells (2021) Vol. 39, Iss. 7, pp. 897-903
Open Access | Times Cited: 28
Stem Cells-Derived Extracellular Vesicles: Potential Therapeutics for Wound Healing in Chronic Inflammatory Skin Diseases
Enzo Manchon, Nell Hirt, Jean‐David Bouaziz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3130-3130
Open Access | Times Cited: 25
Mesenchymal stromal cells in wound healing applications: role of the secretome, targeted delivery and impact on recessive dystrophic epidermolysis bullosa treatment
Julia Riedl, Courtney Popp, Cindy Eide, et al.
Cytotherapy (2021) Vol. 23, Iss. 11, pp. 961-973
Open Access | Times Cited: 25
The therapeutic and commercial landscape of stem cell vesicles in regenerative dermatology
Owen G. Davies, Soraya Williams, Kate Goldie
Journal of Controlled Release (2022) Vol. 353, pp. 1096-1106
Open Access | Times Cited: 17
The Utilization of Human Placental Mesenchymal Stem Cell Derived Exosomes in Aging Skin: An Investigational Pilot Study

Journal of Surgery (2021)
Closed Access | Times Cited: 20
Proteomic analysis of bone marrow-derived mesenchymal stem cell extracellular vesicles from healthy donors: implications for proliferation, angiogenesis, Wnt signaling, and the basement membrane
Jeffrey D. McBride, Luis Rodriguez-Menocal, Wellington Guzman, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Mesenchymal Stem Cell–Derived Extracellular Vesicles as an Advanced Therapy for Chronic Wounds
Eric R. Bray, Robert S. Kirsner, Evangelos V. Badiavas
Cold Spring Harbor Perspectives in Biology (2022) Vol. 14, Iss. 10, pp. a041227-a041227
Closed Access | Times Cited: 12
Preclinical and Clinical Studies on the Use of Extracellular Vesicles Derived from Mesenchymal Stem Cells in the Treatment of Chronic Wounds
Soheila Rezaei, Mohammad Ali Nilforoushzadeh, Mohammad Amir Amirkhani, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 6, pp. 2637-2658
Closed Access | Times Cited: 2
Challenges in Treating Genodermatoses: New Therapies at the Horizon
Marie‐Anne Morren, Eric Legius, Fabienne Giuliano, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 12
Current Perspectives on Adult Mesenchymal Stromal Cell-Derived Extracellular Vesicles: Biological Features and Clinical Indications
Giusi Alberti, Eleonora Russo, Simona Corrao, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2822-2822
Open Access | Times Cited: 12
Human Mesenchymal Stromal Cells Engineered to Express Collagen VII Can Restore Anchoring Fibrils in Recessive Dystrophic Epidermolysis Bullosa Skin Graft Chimeras
Anastasia Petrova, Christos Georgiadis, Roland A. Fleck, et al.
Journal of Investigative Dermatology (2019) Vol. 140, Iss. 1, pp. 121-131.e6
Open Access | Times Cited: 16
The Current Status and Future Direction of Extracellular Nano-vesicles in the Alleviation of Skin Disorders
Raziyeh Ghorbani, Simzar Hosseinzadeh, Arezo Azari, et al.
Current Stem Cell Research & Therapy (2023) Vol. 19, Iss. 3, pp. 351-366
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top